Experimental west nile virus infection in rabbits: An alternative model for studying induction of disease and virus control

Pathogens

Volumn 4, Issue 3, 2015, Pages 529-558

  Suen, Willy W ^a   Uddin, Muhammad J ^a   Wang, Wenqi ^a   Brown, Vienna ^b   Adney, Danielle R ^b   Broad, Nicole ^c   Prow, Natalie A ^a,c   Bowen, Richard A ^b   Hall, Roy A ^a   Bielefeldt Ohmann, Helle ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Animal models; Pathogenesis; Rabbit; West Nile virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; NEUTRALIZING ANTIBODY;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEVER; HISTOPATHOLOGY; LEUKEMIC INFILTRATION; MURRAY VALLEY ENCEPHALITIS VIRUS; MYOCARDITIS; NEUROPATHOLOGY; NONHUMAN; ORYCTOLAGUS CUNICULUS; PHENOTYPE; POPLITEAL LYMPH NODE; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SYLVILAGUS; VIREMIA; VIRUS INFECTION; VIRUS LOAD; WEST NILE VIRUS INFECTION;

EID: 84962747157     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens4030529     Document Type: Article

References (69)

1. Mostashari, F.; Bunning, M.L.; Kitsutani, P.T.; Singer, D.A.; Nash, D.; Cooper, M.J.; Katz, N.; Liljebjelke, K.A.; Biggerstaff, B.J.; Fine, A.D.; et al. Epidemic west nile encephalitis, new york, 1999: Results of a household-based seroepidemiological survey. Lancet 2001, 358, 261-264.
2. Zou, S.; Foster, G.A.; Dodd, R.Y.; Petersen, L.R.; Stramer, S.L. West nile fever characteristics among viremic persons identified through blood donor screening. J. Infect. Dis. 2010, 202, 1354-1361.
3. Lindsey, N.P.; Staples, J.E.; Lehman, J.A.; Fischer, M. Surveillance for human west nile virus disease-United states, 1999-2008. MMWR Surveill. Summ. 2010, 59, 1-17.
4. Nielsen, C.F.; Reisen, W.K.; Armijos, M.V.; Maclachlan, N.J.; Scott, T.W. High subclinical west nile virus incidence among nonvaccinated horses in northern california associated with low vector abundance and infection. Am. J. Trop. Med. Hyg. 2008, 78, 45-52.
5. Ostlund, E.N.; Crom, R.L.; Pedersen, D.D.; Johnson, D.J.; Williams, W.O.; Schmitt, B.J. Equine west nile encephalitis, united states. Emerg. Infect. Dis. 2001, 7, 665-669.
6. Nolan, M.S.; Schuermann, J.; Murray, K.O. West nile virus infection among humans, texas, USA, 2002-2011. Emerg. Infect. Dis. 2013, 19, 137-139.
7. Diamond, M.S.; Shrestha, B.; Marri, A.; Mahan, D.; Engle, M. B cells and antibody play critical roles in the immediate defense of disseminated infection by west nile encephalitis virus. J. Virol. 2003, 77, 2578-2586.
8. Xiao, S.Y.; Guzman, H.; Zhang, H.; Travassos da Rosa, A.P.; Tesh, R.B. West nile virus infection in the golden hamster (mesocricetus auratus): A model for west nile encephalitis. Emerg. Infect. Dis. 2001, 7, 714-721.
9. Prow, N.A.; Setoh, Y.X.; Biron, R.M.; Sester, D.P.; Kim, K.S.; Hobson-Peters, J.; Hall, R.A.; Bielefeldt-Ohmann, H. The west nile-like flavivirus koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response. J. Virol. 2014, 188, 9947-9962.
10. Suen, W.W.; Prow, N.A.; Hall, R.A.; Bielefeldt-Ohmann, H. Mechanism of west nile virus neuroinvasion: A critical appraisal. Viruses 2014, 6, 2796-2825.
11. Guarner, J.; Shieh, W.J.; Hunter, S.; Paddock, C.D.; Morken, T.; Campbell, G.L.; Marfin, A.A.; Zaki, S.R. Clinicopathologic study and laboratory diagnosis of 23 cases with west nile virus encephalomyelitis. Hum. Pathol. 2004, 35, 983-990.
12. Cantile, C.; Del Piero, F.; di Guardo, G.; Arispici, M. Pathologic and immunohistochemical findings in naturally occuring west nile virus infection in horses. Vet. Pathol. 2001, 38, 414-421.
13. Bunning, M.L.; Bowen, R.A.; Cropp, C.B.; Sullivan, K.G.; Davis, B.S.; Komar, N.; Godsey, M.S.; Baker, D.; Hettler, D.L.; Holmes, D.A.; et al. Experimental infection of horses with west nile virus. Emerg. Infect. Dis. 2002, 8, 380-386.
14. Kumar, M.; OʼConnell, M.; Namekar, M.; Nerurkar, V.R. Infection with non-lethal west nile virus eg101 strain induces immunity that protects mice against the lethal west nile virus ny99 strain. Viruses 2014, 6, 2328-2339.
15. Shirato, K.; Kimura, T.; Mizutani, T.; Kariwa, H.; Takashima, I. Different chemokine expression in lethal and non-lethal murine west nile virus infection. J. Med. Virol. 2004, 74, 507-513.
16. Frost, M.J.; Zhang, J.; Edmonds, J.H.; Prow, N.A.; Gu, X.; Davis, R.; Hornitzky, C.; Arzey, K.E.; Finlaison, D.; Hick, P.; et al. Characterization of virulent west nile virus kunjin strain, australia, 2011. Emerg. Infect. Dis. 2012, 18, 792-800.
17. Venter, M.; Human, S.; Zaayman, D.; Gerdes, G.H.; Williams, J.; Steyl, J.; Leman, P.A.; Paweska, J.T.; Setzkorn, H.; Rous, G.; et al. Lineage 2 west nile virus as cause of fatal neurologic disease in horses, south africa. Emerg. Infect. Dis. 2009, 15, 877-884.
18. Lobigs, M.; Marshall, I.D.; Weir, R.C.; Dalgarno, L. Genetic differentiation of murray valley encephalitis virus in australia and papua new guinea. Aust. J. Exp. Biol. Med. Sci. 1986, 64, 571-585.
19. Blitvich, B.J.; Bowen, R.A.; Marlenee, N.L.; Hall, R.A.; Bunning, M.L.; Beaty, B.J. Epitope-blocking enzyme-linked immunosorbent assays for detection of west nile virus antibodies in domestic mammals. J. Clin. Microbiol. 2003, 41, 2676-2679.
20. Dayan, G.H.; Bevilacqua, J.; Coleman, D.; Buldo, A.; Risi, G. Phase II, dose ranging study of the safety and immunogenicity of single dose west nile vaccine in healthy adults ≥50 years of age. Vaccine 2012, 30, 6656-6664.
21. Ratterree, M.S.; Gutierrez, R.A.; Travassos da Rosa, A.P.; Dille, B.J.; Beasley, D.W.; Bohm, R.P.; Desai, S.M.; Didier, P.J.; Bikenmeyer, L.G.; Dawson, G.J.; et al. Experimental infection of rhesus macaques with west nile virus: Level and duration of viremia and kinetics of the antibody response after infection. J. Infect. Dis. 2004, 189, 669-676.
22. Seino, K.K.; Long, M.T.; Gibbs, E.P.; Bowen, R.A.; Beachboard, S.E.; Humphrey, P.P.; Dixon, M.A.; Bourgeois, M.A. Comparative efficacies of three commercially available vaccines against west nile virus (wnv) in a short-duration challenge trial involving an equine wnv encephalitis model. Clin. Vaccine Immunol. 2007, 14, 1465-1471.
23. Castillo-Olivares, J.; Mansfield, K.L.; Phipps, L.P.; Johnson, N.; Tearle, J.; Fooks, A.R. Antibody response in horses following experimental infection with west nile virus lineages 1 and 2. Transbound. Emerg. Dis. 2011, 58, 206-212.
24. Busch, M.P.; Kleinman, S.H.; Tobler, L.H.; Kamel, H.T.; Norris, P.J.; Walsh, I.; Matud, J.L.; Prince, H.E.; Lanciotti, R.S.; Wright, D.J.; et al. Virus and antibody dynamics in acute west nile virus infection. J. Infect. Dis. 2008, 198, 984-993.
25. Styer, L.M.; Kent, K.A.; Albright, R.G.; Bennett, C.J.; Kramer, L.D.; Bernard, K.A. Mosquitoes inoculate high doses of west nile virus as they probe and feed on live hosts. PLoS Pathog. 2007, 3, 1262-1270.
26. Lobigs, M.; Marshall, I.D.; Weir, R.C.; Dalgarno, L. Murray valley encephalitis virus field strains from australia and papua new guinea: Studies on the sequence of the major envelope protein gene and virulence for mice. Virology 1988, 165, 245-255.
27. Brown, A.N.; Kent, K.A.; Bennett, C.J.; Bernard, K.A. Tissue tropism and neuroinvasion of west nile virus do not differ for two mouse strains with different survival rates. Virology 2007, 368, 422-430.
28. Epp, T.; Waldner, C.; West, K.; Townsend, H. Factors associated with west nile virus disease fatalities in horses. Can. Vet. J. 2007, 48, 1137-1145.
29. Byrne, S.N.; Halliday, G.M.; Johnston, L.J.; King, N.J. Interleukin-1beta but not tumor necrosis factor is involved in west nile virus-induced langerhans cell migration from the skin in c57bl/6 mice. J. Investig. Dermatol. 2001, 117, 702-709.
30. Johnston, L.J.; Halliday, G.M.; King, N.J. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J. Investig. Dermatol. 2000, 114, 560-568.
31. Tiawsirisup, S.; Platt, K.B.; Tucker, B.J.; Rowley, W.A. Eastern cottontail rabbits (sylvilagus floridanus) develop west nile virus viremias sufficient for infecting select mosquito species. Vector Borne Zoonotic Dis. 2005, 5, 342-350.
32. Kay, B.H.; Young, P.L.; Hall, R.A.; Fanning, I.D. Experimental infection with murray valley encephalitis virus. Pigs, cattle, sheep, dogs, rabbits, macropods and chickens. Aust. J. Exp. Biol. Med. Sci. 1985, 63, 109-126.
33. Verstrepen, B.E.; Fagrouch, Z.; van Heteren, M.; Buitendijk, H.; Haaksma, T.; Beenhakker, N.; Palu, G.; Richner, J.M.; Diamond, M.S.; Bogers, W.M.; et al. Experimental infection of rhesus macaques and common marmosets with a european strain of west nile virus. PLoS Negl. Trop. Dis. 2014, 8, e2797.
34. Smith, R.D.; Konoplev, S.; DeCourten-Myers, G.; Brown, T. West nile virus encephalitis with myositis and orchitis. Hum. Pathol. 2004, 35, 254-258.
35. McMinn, P.C.; Dalgarno, L.; Weir, R.C. A comparison of the spread of murray valley encephalitis viruses of high or low neuroinvasiveness in the tissues of swiss mice after peripheral inoculation. Virology 1996, 220, 414-423.
36. Hussmann, K.L.; Samuel, M.A.; Kim, K.S.; Diamond, M.S.; Fredericksen, B.L. Differential replication of pathogenic and nonpathogenic strains of west nile virus within astrocytes. J. Virol. 2013, 87, 2814-2822.
37. Laurent-Rolle, M.; Boer, E.F.; Lubick, K.J.; Wolfinbarger, J.B.; Carmody, A.B.; Rockx, B.; Liu, W.; Ashour, J.; Shupert, W.L.; Holbrook, M.R.; et al. The ns5 protein of the virulent west nile virus ny99 strain is a potent antagonist of type i interferon-mediated jak-stat signaling. J. Virol. 2010, 84, 3503-3515.
38. Keller, B.C.; Fredericksen, B.L.; Samuel, M.A.; Mock, R.E.; Mason, P.W.; Diamond, M.S.; Gale, M., Jr. Resistance to alpha/beta interferon is a determinant of west nile virus replication fitness and virulence. J. Virol. 2006, 80, 9424-9434.
39. Purtha, W.E.; Chachu, K.A.; Virgin, H.W.T.; Diamond, M.S. Early b-cell activation after west nile virus infection requires alpha/beta interferon but not antigen receptor signaling. J. Virol. 2008, 82, 10964-10974.
40. Hayes, E.B.; Sejvar, J.J.; Zaki, S.R.; Lanciotti, R.S.; Bode, A.V.; Campbell, G.L. Virology, pathology, and clinical manifestations of west nile virus disease. Emerg. Infect. Dis. 2005, 11, 1174-1179.
41. Neves, P.C.C.; Santos, J.R.; Tubarão, L.N.; Bonaldo, M.C.; Galler, R. Early ifn-gamma production after yf 17d vaccine virus immunization in mice and its association with adaptive immune responses. PLoS ONE 2013, 8, e81953.
42. Lopez-Griego, L.; Nava-Castro, K.E.; Lopez-Salazar, V.; Hernandez-Cervantes, R.; Tiempos Guzman, N.; Muniz-Hernandez, S.; Hernandez-Bello, R.; Besedovsky, H.O.; Pavon, L.; Becerril Villanueva, L.E.; et al. Gender-associated differential expression of cytokines in specific areas of the brain during helminth infection. J. Interferon Cytokine Res. 2015, 35, 116-125.
43. Peng, S.Y.; Chu, T.H.; Wang, I.C.; Chung, W.C.; Yu, K.W.; Tsaihong, J.C.; Huang, J.C.; Fan, P.C. Infection of normal c3h/hen mice with taenia saginata asiatica oncospheres. Res. Vet. Sci. 2009, 86, 261-266.
44. MacMicking, J.; Xie, Q.W.; Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15, 323-350.
45. Kreutzberg, G.W. Microglia: A sensor for pathological events in the cns. Trends Neurosci. 1996, 19, 312-318.
46. Miller, J.D.; van der Most, R.G.; Akondy, R.S.; Glidewell, J.T.; Albott, S.; Masopust, D.; Murali-Krishna, K.; Mahar, P.L.; Edupuganti, S.; Lalor, S.; et al. Human effector and memory cd8(+) t cell responses to smallpox and yellow fever vaccines. Immunity 2008, 28, 710-722.
47. Dittmer, U.; Peterson, K.E.; Messer, R.; Stromnes, I.M.; Race, B.; Hasenkrug, K.J. Role of interleukin-4 (il-4), il-12, and gamma interferon in primary and vaccine-primed immune responses to friend retrovirus infection. J. Virol. 2001, 75, 654-660.
48. Liu, S.Y.; Sanchez, D.J.; Aliyari, R.; Lu, S.; Cheng, G. Systematic identification of type i and type ii interferon-induced antiviral factors. Proc. Natl. Acad. Sci. USA 2012, 109, 4239-4244.
49. Girdlestone, J.; Wing, M. Autocrine activation by interferon-gamma of stat factors following t cell activation. Eur. J. Immunol. 1996, 26, 704-709.
50. Christmas, S.E.; Meager, A. Production of interferon-gamma and tumor-necrosis-factor-alpha by human t-cell clones expressing different forms of the gamma-delta-receptor. Immunology 1990, 71, 486-492.
51. Biron, C.A.; Nguyen, K.B.; Pien, G.C.; Cousens, L.P.; Salazar-Mather, T.P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu. Rev. Immunol. 1999, 17, 189-220.
52. Omalu, B.I.; Shakir, A.A.; Wang, G.; Lipkin, W.I.; Wiley, C.A. Fatal fulminant pan-meningo-polioencephalitis due to west nile virus. Brain Pathol. 2003, 13, 465-472.
53. Maximova, O.A.; Ward, J.M.; Asher, D.M.; St Claire, M.; Finneyfrock, B.W.; Speicher, J.M.; Murphy, B.R.; Pletnev, A.G. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates. J. Virol. 2008, 82, 5255-5268.
54. Pusterla, N.; Wilson, W.D.; Conrad, P.A.; Mapes, S.; Leutenegger, C.M. Comparative analysis of cytokine gene expression in cerebrospinal fluid of horses without neurologic signs or with selected neurologic disorders. Am. J. Vet. Res. 2006, 67, 1433-1437.
55. Wei, Y.P.; Kita, M.; Shinmura, K.; Yan, X.Q.; Fukuyama, R.; Fushiki, S.; Imanishi, J. Expression of ifn-gamma in cerebrovascular endothelial cells from aged mice. J. Interferon Cytokine Res. 2000, 20, 403-409.
56. Neumann, H.; Schmidt, H.; Wilharm, E.; Behrens, L.; Wekerle, H. Interferon gamma gene expression in sensory neurons: Evidence for autocrine gene regulation. J. Exp. Med. 1997, 186, 2023-2031.
57. Beasley, D.W.; Barrett, A.D.; Tesh, R.B. Resurgence of west nile neurologic disease in the united states in 2012: What happened? What needs to be done? Antivir. Res. 2013, 99, 1-5.
58. Dalgarno, L.; Trent, D.W.; Strauss, J.H.; Rice, C.M. Partial nucleotide sequence of the murray valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. J. Mol. Biol. 1986, 187, 309-323.
59. Lorenz, M.D.; Coates, J.R.; Kent, M. Handbook of Veterinary Neurology, 5th ed.; Elsevier/Saunders: St. Louis, MI, USA, 2011; p. 28.
60. Tolnay, A.E.; Baskin, C.R.; Tumpey, T.M.; Sabourin, P.J.; Sabourin, C.L.; Long, J.P.; Pyles, J.A.; Albrecht, R.A.; Garcia-Sastre, A.; Katze, M.G.; et al., Extrapulmonary tissue responses in cynomolgus macaques (macaca fascicularis) infected with highly pathogenic avian influenza a (h5n1) virus. Arch. Virol. 2010, 155, 905-914.
61. Hall, R.A.; Kay, B.H.; Burgess, G.W. An enzyme immunoassay to detect australian flaviviruses and identify the encephalitic subgroup using monoclonal antibodies. Immunol. Cell Biol. 1987, 65, 103-110.
62. Bowen, R.A.; Rouge, M.M.; Siger, L.; Minke, J.M.; Nordgren, R.; Karaca, K.; Johnson, J. Pathogenesis of west nile virus infection in dogs treated with glucocorticoids. Am. J. Trop. Med. Hyg. 2006, 74, 670-673.
63. Prow, N.A.; Tan, C.S.; Wang, W.; Hobson-Peters, J.; Kidd, L.; Barton, A.; Wright, J.; Hall, R.A.; Bielefeldt-Ohmann, H. Natural exposure of horses to mosquito-borne flaviviruses in south-east queensland, australia. Int. J. Environ. Res. Public. Health 2013, 10, 4432-4443.
64. Prow, N.A.; Hewlett, E.K.; Faddy, H.M.; Coiacetto, F.; Wang, W.; Cox, T.; Hall, R.A.; Bielefeldt-Ohmann, H. The australian public is still vulnerable to emerging virulent strains of west nile virus. Front. Public Health 2014, 2, 146.
65. Pyke, A.T.; Smith, I.L.; van den Hurk, A.F.; Northill, J.A.; Chuan, T.F.; Westacott, A.J.; Smith, G.A. Detection of australasian flavivirus encephalitic viruses using rapid fluorogenic taqman rt-pcr assays. J. Virol. Methods 2004, 117, 161-167.
66. Lanciotti, R.S.; Kerst, A.J.; Nasci, R.S.; Godsey, M.S.; Mitchell, C.J.; Savage, H.M.; Komar, N.; Panella, N.A.; Allen, B.C.; Volpe, K.E.; et al. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a taqman reverse transcriptase-pcr assay. J. Clin. Microbiol. 2000, 38, 4066-4071.
67. Schnupf, P.; Sansonetti, P.J. Quantitative rt-pcr profiling of the rabbit immune response: Assessment of acute shigella flexneri infection. PLoS ONE 2012, 7, e36446.
68. Pfaffl, M.W. A new mathematical model for relative quantification in real-time rt-pcr. Nucl. Acids Res. 2001, 29, e45.
69. Smirnova, N.P.; Webb, B.T.; Bielefeldt-Ohmann, H.; Van Campen, H.; Antoniazzi, A.Q.; Morarie, S.E.; Hansen, T.R. Development of fetal and placental innate immune responses during establishment of persistent infection with bovine viral diarrhea virus. Virus Res. 2012, 167, 329-336.